The Cost-Effectiveness of Initial Treatment of Multiple...

The Oncologist 2013 / 01 Vol. 18; Iss. 1

The Cost-Effectiveness of Initial Treatment of Multiple Myeloma in the U.S. With Bortezomib Plus Melphalan and Prednisone Versus Thalidomide Plus Melphalan and Prednisone or Lenalidomide Plus Melphalan and Prednisone With Continuous Lenalidomide Maintenance Treatment

Garrison, L. P., Wang, S.-T., Huang, H., Ba-Mancini, A., Shi, H., Chen, K., Korves, C., Dhawan, R., Cakana, A., van de Velde, H., Corzo, D., Duh, M. S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2011-0380
Date:
January, 2013
File:
PDF, 179 KB
english, 2013
Conversion to is in progress
Conversion to is failed